Perez, J. R., Hernández, R., Lage, Y., Rupérez, A. B., Ruiz, E., Hernández, T., … Moreno</p, V. (2020). Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient Treated with a Novel Combination Treatment with Anti PDL1 Antibody (Durvalumab) and VEGFR2 Antibody (Ramucirumab). Archives of Clinical and Medical Case Reports, 4(1), 8–14. Retrieved from https://fortunejournals.org/ojs/index.php/acmcr/article/view/22266